{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:36:17Z","timestamp":1779240977011,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.otc.2020.03.012","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T01:06:14Z","timestamp":1587603974000},"page":"651-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Current Clinical Trials for Tinnitus"],"prefix":"10.1016","volume":"53","author":[{"given":"Jonas","family":"Dyhrfjeld-Johnsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Cederroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.otc.2020.03.012_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S1474-4422(13)70160-1","article-title":"Tinnitus: causes and clinical management","volume":"12","author":"Langguth","year":"2013","journal-title":"Lancet Neurol"},{"issue":"9830","key":"10.1016\/j.otc.2020.03.012_bib2","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0140-6736(12)60469-3","article-title":"Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial","volume":"379","author":"Cima","year":"2012","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.otc.2020.03.012_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00106-019-0633-7","article-title":"A\u00a0multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment","volume":"67","author":"Cima","year":"2019","journal-title":"HNO"},{"issue":"11","key":"10.1016\/j.otc.2020.03.012_bib4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/nbt.2736","article-title":"Hearing loss and tinnitus--are funders and industry listening?","volume":"31","author":"Cederroth","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.otc.2020.03.012_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-pharmtox-010818-021556","article-title":"Therapeutic approaches to the treatment of tinnitus","volume":"59","author":"Langguth","year":"2019","journal-title":"Annu Rev PharmacolToxicol"},{"issue":"4","key":"10.1016\/j.otc.2020.03.012_bib6","first-page":"251","article-title":"An update: emerging drugs for tinnitus","volume":"23","author":"Cederroth","year":"2018","journal-title":"ExpertOpinEmergDrugs"},{"issue":"8","key":"10.1016\/j.otc.2020.03.012_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archotol.1982.00790560009003","article-title":"Lidocaine in the treatment of tinnitus aurium.A double-blind study","volume":"108","author":"Israel","year":"1982","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.otc.2020.03.012_bib8","first-page":"303","article-title":"Lidocaine: neurobiological targets and effects on the auditory system","volume":"166","author":"Trellakis","year":"2007","journal-title":"ProgBrain Res"},{"key":"10.1016\/j.otc.2020.03.012_bib9","first-page":"53","article-title":"Editorial: towards an understanding of tinnitus heterogeneity","volume":"11","author":"Cederroth","year":"2019","journal-title":"Front AgingNeurosci"},{"issue":"3","key":"10.1016\/j.otc.2020.03.012_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrneurol.2016.12","article-title":"Maladaptive plasticity in tinnitus--triggers, mechanisms and treatment","volume":"12","author":"Shore","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.otc.2020.03.012_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07242","article-title":"Noise-induced plasticity of KCNQ2\/3 and HCN channels underlies vulnerability and resilience to tinnitus","volume":"4","author":"Li","year":"2015","journal-title":"Elife"},{"issue":"36","key":"10.1016\/j.otc.2020.03.012_bib12","doi-asserted-by":"crossref","first-page":"14974","DOI":"10.1073\/pnas.1107998108","article-title":"Homeostatic plasticity drives tinnitus perception in an animal model","volume":"108","author":"Yang","year":"2011","journal-title":"ProcNatlAcadSci U\u00a0S\u00a0A"},{"key":"10.1016\/j.otc.2020.03.012_bib13","doi-asserted-by":"crossref","first-page":"e06576","DOI":"10.7554\/eLife.06576","article-title":"Tinnitus and hyperacusis involve hyperactivity and enhanced connectivity in auditory-limbic-arousal-cerebellar network","volume":"4","author":"Chen","year":"2015","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.otc.2020.03.012_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2010.12.002","article-title":"Dysregulation of limbic and auditory networks in tinnitus","volume":"69","author":"Leaver","year":"2011","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.otc.2020.03.012_bib15","doi-asserted-by":"crossref","first-page":"e3720","DOI":"10.1371\/journal.pone.0003720","article-title":"Using auditory steady state responses to outline the functional connectivity in the tinnitus brain","volume":"3","author":"Schlee","year":"2008","journal-title":"PLoSOne"},{"issue":"1","key":"10.1016\/j.otc.2020.03.012_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41467-018-02820-0","article-title":"Thalamocortical dysrhythmia detected by machine learning","volume":"9","author":"Vanneste","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.otc.2020.03.012_bib17","first-page":"1905","article-title":"Cochlear NMDA receptors as a therapeutic target of noise-induced tinnitus","volume":"35","author":"Bing","year":"2015","journal-title":"Cell PhysiolBiochem"},{"issue":"9","key":"10.1016\/j.otc.2020.03.012_bib18","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1523\/JNEUROSCI.23-09-03944.2003","article-title":"Salicylate induces tinnitus through activation of cochlear NMDA receptors","volume":"23","author":"Guitton","year":"2003","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.otc.2020.03.012_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0378-5955(91)90042-8","article-title":"Electrophysiological evidence for the presence of NMDA receptors in the guinea pig cochlea","volume":"51","author":"Puel","year":"1991","journal-title":"Hear Res"},{"issue":"1","key":"10.1016\/j.otc.2020.03.012_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5955(91)90188-F","article-title":"Glutamate receptors in afferent cochlear neurotransmission in guinea pigs","volume":"52","author":"Ehrenberger","year":"1991","journal-title":"Hear Res"},{"issue":"1","key":"10.1016\/j.otc.2020.03.012_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0006-8993(91)90862-P","article-title":"Kainate and NMDA toxicity for cultured developing and adult rat spiral ganglion neurons: further evidence for a glutamatergic excitatory neurotransmission at the inner hair cell synapse","volume":"555","author":"Lefebvre","year":"1991","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.otc.2020.03.012_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00001756-199204000-00002","article-title":"Implication of non-NMDA and NMDA receptors in cochlear ischemia","volume":"3","author":"Pujol","year":"1992","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.otc.2020.03.012_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.903410209","article-title":"Excitatory amino acid antagonists protect cochlear auditory neurons from excitotoxicity","volume":"341","author":"Puel","year":"1994","journal-title":"J\u00a0Comp Neurol"},{"issue":"3","key":"10.1016\/j.otc.2020.03.012_bib24","first-page":"330","article-title":"Pathophysiology of the glutamatergic synapses in the cochlea","volume":"113","author":"Pujol","year":"1993","journal-title":"ActaOtolaryngol"},{"key":"10.1016\/j.otc.2020.03.012_bib25","first-page":"80904","article-title":"Blockade of cochlear NMDA receptors prevents long-term tinnitus during a brief consolidation window after acoustic trauma","volume":"2007","author":"Guitton","year":"2007","journal-title":"NeuralPlast"},{"issue":"5","key":"10.1016\/j.otc.2020.03.012_bib26","first-page":"559","article-title":"Hearing protection, restoration, and regeneration: an overview of emerging therapeutics for inner ear and central hearing disorders","volume":"40","author":"Schilder","year":"2019","journal-title":"OtolNeurotol"},{"issue":"4","key":"10.1016\/j.otc.2020.03.012_bib29","first-page":"589","article-title":"Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus--a double-blind, randomized, placebo-controlled phase II study","volume":"35","author":"van de Heyning","year":"2014","journal-title":"OtolNeurotol"},{"issue":"3","key":"10.1016\/j.otc.2020.03.012_bib30","first-page":"172","article-title":"Selecting appropriate dose regimens for AM-101 in the intratympanic treatment of acute inner ear tinnitus","volume":"20","author":"Staecker","year":"2015","journal-title":"AudiolNeurootol"},{"issue":"3","key":"10.1016\/j.otc.2020.03.012_bib31","first-page":"478","article-title":"Safety of repeated-dose intratympanic injections with AM-101 in acute inner ear tinnitus","volume":"157","author":"Staecker","year":"2017","journal-title":"OtolaryngolHeadNeck Surg"},{"key":"10.1016\/j.otc.2020.03.012_bib32","series-title":"Innovative treatments for inner ear disorders.Keyzilen TM program update","author":"Auris Medical","year":"2016"},{"issue":"5","key":"10.1016\/j.otc.2020.03.012_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00405-009-1126-1","article-title":"Effects of extracochleargacyclidine perfusion on tinnitus in humans: a case series","volume":"267","author":"Wenzel","year":"2010","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"Suppl 1","key":"10.1016\/j.otc.2020.03.012_bib38","first-page":"53","article-title":"Revisiting the cochlear and central mechanisms of tinnitus and therapeutic approaches","volume":"20","author":"Nore\u00f1a","year":"2015","journal-title":"AudiolNeurootol"},{"key":"10.1016\/j.otc.2020.03.012_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.heares.2012.09.010","article-title":"Tinnitus-related neural activity: theories of generation, propagation, and centralization","volume":"295","author":"Nore\u00f1a","year":"2013","journal-title":"Hear Res"},{"issue":"9","key":"10.1016\/j.otc.2020.03.012_bib40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/1087057115601677","article-title":"Neuronal and cardiovascular potassium channels as therapeutic drug targets: promise and pitfalls","volume":"20","author":"Humphries","year":"2015","journal-title":"J\u00a0Biomol Screen"},{"issue":"16","key":"10.1016\/j.otc.2020.03.012_bib41","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/bph.13889","article-title":"Big conductance calcium-activated potassium channel openers control spasticity without sedation","volume":"174","author":"Baker","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.otc.2020.03.012_bib42","unstructured":"Farrell R, Selwood D, Baker D, CanbexVSN16R Spasticity Study Group. P1797 - Results from a phase II proof of concept trial of VSN16R to treat multiple sclerosis related spasticity. 34th Congres of the European Committee for Treatment and Research in Multiple Sclerosis. 10-12 October 2018. Berlin. Germany. Available at: http:\/\/www.professionalabstracts.com\/ectrims2018\/iplanner\/#\/presentation\/2371. Accessed December 20, 2019."},{"issue":"3","key":"10.1016\/j.otc.2020.03.012_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ph12030104","article-title":"The cannabinoid-like compound, VSN16R, acts on large conductance, Ca2+-activated K+ channels to modulate hippocampal CA1pyramidal neuron firing","volume":"12","author":"Tabatabaee","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.otc.2020.03.012_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2014.03.017","article-title":"Pharmacodynamics of potassium channel openers in cultured neuronal networks","volume":"732","author":"Wu","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"24","key":"10.1016\/j.otc.2020.03.012_bib46","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1073\/pnas.1302770110","article-title":"Pathogenic plasticity of Kv7.2\/3 channel activity is essential for the induction of tinnitus","volume":"110","author":"Li","year":"2013","journal-title":"ProcNatlAcadSci U\u00a0S\u00a0A"},{"issue":"5","key":"10.1016\/j.otc.2020.03.012_bib47","first-page":"873","article-title":"Effects of the potassium ion channel modulators BMS-204352 Maxipost and its R-enantiomer on salicylate-induced tinnitus in rats","volume":"104","author":"Lobarinas","year":"2011","journal-title":"PhysiolBehav"},{"key":"10.1016\/j.otc.2020.03.012_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2015.04.007","article-title":"Potassium ion channel openers, Maxipost and Retigabine, protect against peripheral salicylate ototoxicity in rats","volume":"327","author":"Sheppard","year":"2015","journal-title":"Hear Res"},{"issue":"1","key":"10.1016\/j.otc.2020.03.012_bib49","doi-asserted-by":"crossref","first-page":"17496","DOI":"10.1038\/s41598-017-17406-x","article-title":"Pharmacological modulation of Kv3.1 mitigates auditory midbrain temporal processing deficits following auditory nerve damage","volume":"7","author":"Chambers","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.otc.2020.03.012_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.heares.2018.04.012","article-title":"Increased spontaneous firing rates in auditory midbrain following noise exposure are specifically abolished by a Kv3 channel modulator","volume":"365","author":"Anderson","year":"2018","journal-title":"Hear Res"},{"key":"10.1016\/j.otc.2020.03.012_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.heares.2018.01.017","article-title":"Effects of AUT00063, a Kv3.1 channel modulator, on noise-induced hyperactivity in the dorsal cochlear nucleus","volume":"361","author":"Glait","year":"2018","journal-title":"Hear Res"},{"key":"10.1016\/j.otc.2020.03.012_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.heares.2019.03.018","article-title":"A\u00a0balanced randomised placebo controlled blinded phase IIa multi-centre study to investigate the efficacy and safety of AUT00063 versus placebo in subjective tinnitus: The QUIET-1 trial","volume":"377","author":"Hall","year":"2019","journal-title":"Hear Res"},{"key":"10.1016\/j.otc.2020.03.012_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2019.01.022","article-title":"Residual inhibition: From the putative mechanisms to potential tinnitus treatment","volume":"375","author":"Galazyuk","year":"2019","journal-title":"Hear Res"},{"key":"10.1016\/j.otc.2020.03.012_bib59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuroscience.2014.05.057","article-title":"Metabotropic glutamate receptors in auditory processing","volume":"274","author":"Lu","year":"2014","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.otc.2020.03.012_bib60","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1113\/JP272604","article-title":"mGluR1 enhances efferent inhibition of inner hair cells in the developing rat cochlea","volume":"595","author":"Ye","year":"2017","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.otc.2020.03.012_bib61","first-page":"346","article-title":"Biomarkers of presbycusis and tinnitus in a Portuguese older population","volume":"9","author":"Haider","year":"2017","journal-title":"Front AgingNeurosci"},{"key":"10.1016\/j.otc.2020.03.012_bib63","unstructured":"Amanipour R, Zhu X, Ding B, et\u00a0al. Preclinical evaluation of a novel mGluR7 negative allosteric modulator in a noise-induced hearing loss mouse model.Poster 060.13.Society for Neuroscience Annual Meeting, October 19-23, 2019. Available at: https:\/\/eventpilotadmin.com\/web\/page.php?page=Session&project=SFN19&id=P44568. Accessed December 18, 2019."},{"key":"10.1016\/j.otc.2020.03.012_bib64","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fnins.2019.00802","article-title":"Why is there no cure for tinnitus?","volume":"13","author":"McFerran","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.otc.2020.03.012_bib65","first-page":"741452","article-title":"Animal models of subjective tinnitus","volume":"2014","author":"von der Behrens","year":"2014","journal-title":"NeuralPlast"},{"issue":"1","key":"10.1016\/j.otc.2020.03.012_bib66","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13063-016-1399-9","article-title":"Systematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults","volume":"17","author":"Hall","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.otc.2020.03.012_bib67","first-page":"373","article-title":"BKCa channel dysfunction in neurological diseases","volume":"5","author":"N\u2019Gouemo","year":"2014","journal-title":"Front Physiol"},{"issue":"23","key":"10.1016\/j.otc.2020.03.012_bib68","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1523\/JNEUROSCI.5176-14.2015","article-title":"Potent KCNQ2\/3-specific channel activator suppresses in\u00a0vivo epileptic activity and prevents the development of tinnitus","volume":"35","author":"Kalappa","year":"2015","journal-title":"J\u00a0Neurosci"},{"issue":"6","key":"10.1016\/j.otc.2020.03.012_bib69","doi-asserted-by":"crossref","first-page":"e3000307","DOI":"10.1371\/journal.pbio.3000307","article-title":"Neuroinflammation mediates noise-induced synaptic imbalance and tinnitus in rodent models","volume":"17","author":"Wang","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/j.otc.2020.03.012_bib70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fnins.2016.00377","article-title":"Genetics of tinnitus: an emerging area for molecular diagnosis and drug development","volume":"10","author":"Lopez-Escamez","year":"2016","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.otc.2020.03.012_bib71","first-page":"222","article-title":"Association of genetic vs environmental factors in swedish adoptees with clinically significant tinnitus","volume":"145","author":"Cederroth","year":"2019","journal-title":"JAMAOtolaryngolHeadNeck Surg"},{"issue":"9","key":"10.1016\/j.otc.2020.03.012_bib72","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/gim.2017.4","article-title":"Genetic susceptibility to bilateral tinnitus in a Swedish twin cohort","volume":"19","author":"Maas","year":"2017","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.otc.2020.03.012_bib73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat Rev DrugDiscov"},{"issue":"3","key":"10.1016\/j.otc.2020.03.012_bib74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2017.244","article-title":"Impact of a five-dimensional framework on R&D productivity at AstraZeneca","volume":"17","author":"Morgan","year":"2018","journal-title":"Nat Rev DrugDiscov"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666520300499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666520300499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:53:26Z","timestamp":1758466406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666520300499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0030666520300499"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2020.03.012","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Clinical Trials for Tinnitus","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2020.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}